EGFR modulators and uses thereof
US9623027B2 · kind B2 · utility
0Cited by
8References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 14, 2015 |
| Grant date | Apr 18, 2017 |
| Priority date | — |
| Expiry date | May 14, 2035 |
Classification
- Technology area (CPC —)General
Abstract
The present invention relates to certain pyrrolopyrimidine derivatives, pharmaceutical compositions containing them, and methods of using them, including methods for the treatment of tumors and related diseases related to the dysregulation of kinase (such as EGFR (including HER), Alk, PDGFR, but not limited to) pathways.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.